The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 501–600 of 1,000
Update in diagnosis and management of primary aldosteronism
Dick, S. M., Queiroz, M., Bernardi, B. L., Dall’Agnol, A., Brondani, L. D. A., & Silveiro, S. P. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0217 · Cited by 28
Mete, Ö., & Duan, K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00054 · Cited by 27
An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI)
Popp, R., Malmström, D., Chambers, A. G., Lin, D., Camenzind, A. G., van der Gugten, J. G., Holmes, D. T., Pugia, M. J., Jaremek, M., Cornett, S., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.10.008 · Cited by 26
2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-1-7-94 · Cited by 26
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
Huang, K., Yu, C., Hu, Y., Chang, C., Chan, C., Liao, S., Tsai, Y., Chueh, S., Wu, V., Lin, Y., et al. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.01.006 · Cited by 26
Bouhanick, B., Delchier, M. C., Lagarde, S., Boulestreau, R., Conil, C., Gosse, P., Rousseau, H., Lepage, B., Olivier, P., Papadopoulos, P., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002708 · Cited by 26
Browne, G. A., Griffin, T. P., O’Shea, P. M., & Dennedy, M. C. (2015) · Clinical Endocrinology · doi:10.1111/cen.12882 · Cited by 26
Velasco, A., Chung, O., Raza, F. S., Pandey, A., Brinker, S., Arbique, D., Price, A. L., Lotan, Y., Das, S. R., & Vongpatanasin, W. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12570 · Cited by 26
Current status and controversies in adrenal incidentalomas
Kaltsas, G., Chrisoulidou, A., Piaditis, G. P., Kassi, E. N., & Chrousos, G. P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.001 · Cited by 26
Prevalence of Hyperaldosteronism in Primary Care Patients with Resistant Hypertension
Schmiemann, G., Gebhardt, K., Hummers, E., & Egidi, G. (2012) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2012.01.110099 · Cited by 26
Arlt, W. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0869 · Cited by 26
Subclinical primary aldosteronism
Ito, Y., Takeda, R., & Takeda, Y. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.11.006 · Cited by 26
Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension
Jansen, P. M., Frenkel, W. J., van den Born, B. H., de Bruijne, E. L. E., Deinum, J., Kerstens, M. N., Arnoldus, J. H. A., Woittiez, A. J. J., Wijbenga, J. A. M., Zietse, R., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835b71d6 · Cited by 26
GNAS mutations in adrenal aldosterone-producing adenomas [Rapid Communication]
Nakajima, Y., Okamura, T., Horiguchi, K., Gohko, T., Miyamoto, T., Satoh, T., Ozawa, A., Ishii, S., Yamada, E., Hashimoto, K., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej15-0642 · Cited by 26
Umakoshi, H., Naruse, M., Wada, N., Ichijo, T., Kamemura, K., Matsuda, Y., Fujii, Y., Kai, T., Fukuoka, T., Sakamoto, R., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06607 · Cited by 26
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis
Bardet, S., Chamontin, B., Douillard, C., Pagny, J.-Y., Hernigou, A., Joffre, F. G., Plouin, P., & Steichen, O. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.008 · Cited by 26
Kim, D. H., Kwon, H. J., Ji, S. A., Jang, H. R., Jung, S.-H., Kim, J., Kim, J. H., Lee, J. E., Huh, W., Kim, Y.-G., et al. (2016) · Medicine · doi:10.1097/md.0000000000003930 · Cited by 26
Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism
Umakoshi, H., Sakamoto, R., Matsuda, Y., Yokomoto‐Umakoshi, M., Nagata, H., Fukumoto, T., Ogata, M., & Ogawa, Y. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz148 · Cited by 26
Sakuma, I., Suematsu, S., Matsuzawa, Y., Saito, J., Omura, M., Maekawa, T., Nakamura, Y., Sasano, H., & Nishikawa, T. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0270 · Cited by 25
Endocrine hypertension — Current understanding and comprehensive management review
Sukor, N. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.05.004 · Cited by 25
Tratamiento del hiperaldosteronismo primario
Castro, M. A. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.04.029 · Cited by 25
Resistant hypertension: consensus document from the Korean society of hypertension
Park, S., Shin, J., Ihm, S., Kim, K., Kim, H., Kim, H. C., Lee, E. M., Lee, J. H., Ahn, S. Y., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00255-4 · Cited by 26
Ospina, N. S., Rodríguez‐Gutiérrez, R., Brito, J. P., Young, W. F., & Montori, V. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0435-z · Cited by 25
Self-citationAT2R Autoantibodies Block Angiotensin II and AT1R Autoantibody-Induced Vasoconstriction
Liles, C., Li, H., Veitla, V., Liles, J. T., Murphy, T. A., Cunningham, M. W., Yu, X., & Kem, D. C. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05428 · Cited by 25
Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations
Fernandes-Rosa, F. L., Amar, L., Tissier, F., Bertherat, J. Y., Méatchi, T., Zennaro, M., & Boulkroun, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.020 · Cited by 25
Fortunato, A., Prontera, C., Masotti, S., Franzini, M., Marchetti, C., Giovannini, S., Zucchelli, G. C., Emdin, M., Passino, C., & Clerico, A. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.028 · Cited by 25
Aldosterone and glomerular filtration – observations in the general population
Hannemann, A., Rettig, R., Dittmann, K., Völzke, H., Endlich, K., Nauck, M. A., & Wallaschofski, H. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-44 · Cited by 25
Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage
Liu, G., Yin, G.-S., Tang, J.-Y., Ma, D.-J., Ru, J., & Huang, X.-H. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.11 · Cited by 25
Tomaschitz, A., Piecha, G., Ritz, E., Meinitzer, A., Haas, J. G., Pieske, B. M., Więcek, A., Rus-Machan, J., Toplak, H., März, W., et al. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.913604 · Cited by 25
Hennings, J., Andréasson, S., Botling, J., Hägg, A., Sundin, A., & Hellman, P. (2009) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-009-0498-4 · Cited by 25
Colussi, G., Novello, M., Uzzau, A., Catena, C., & Sechi, L. A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565128 · Cited by 25
Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats
Ball, J. P., Syed, M., Maranon, R. O., Hall, M. E., Roshan, K. C., Reckelhoff, J. F., Cardozo, L. L. Y., & Romero, D. G. (2017) · Endocrinology · doi:10.1210/en.2016-1707 · Cited by 25
Approach to the surgical management of primary aldosteronism.
Iacobone, M., Citton, M., Viel, G., Rossi, G. P., & Nitti, D. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2227-684x.2015.01.05 · Cited by 28
Siracuse, J. J., Gill, H. L., Epelboym, I., Clarke, N. C., Kabutey, N.-K., Kim, I.-K., Lee, J. A., & Morrissey, N. J. (2013) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2013.10.009 · Cited by 25
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma
Giacchetti, G., Ronconi, V., Rilli, S., Guerrieri, M., Turchi, F., & Boscaro, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0902 · Cited by 25
Araujo-Castro, M., García Cano, A., Jiménez Mendiguchía, L., Escobar-Morreale, H. F., & Valderrábano, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-00011-4 · Cited by 24
Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development
Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00095 · Cited by 24
Rosa, J., Zelinka, T., Petrák, O., Štrauch, B., Šomlóová, Z., Indra, T., Holaj, R., Čurila, K., Toušek, P., Šenitko, M., et al. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.3 · Cited by 24
Role of adrenal vein sampling in primary aldosteronism: Impact of imaging, localization, and age
Wachtel, H., Zaheer, S., Shah, P., Trerotola, S. O., Karakousis, G. C., Roses, R. E., Cohen, D. L., & Fraker, D. L. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24182 · Cited by 24
Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: A multicentre study
Ducher, M., Mounier‐Véhier, C., Baguet, J.-P., Tartière, J., Sosner, P., Coz, S. R.-L., Perez, L., Fourcade, J., Jaboureck, O., Jeune, S. L., et al. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2012.07.006 · Cited by 24
Unilateral Primary Aldosteronism with Spontaneous Remission after Long-Term Spironolactone Therapy
Yoneda, T., Demura, M., Takata, H., Kometani, M., Karashima, S., Yamagishi, M., & Takeda, Y. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2563 · Cited by 24
Willenberg, H. S., Späth, M. R., Maser‐Gluth, C., Engers, R., Anlauf, M., Dekomien, G., Schott, M., Schinner, S., Cupisti, K., & Scherbaum, W. A. (2010) · Hypertension Research · doi:10.1038/hr.2010.18 · Cited by 24
Integrating Genetics and Genomics in Primary Aldosteronism
Zennaro, M., Jeunemaı̂tre, X., & Boulkroun, S. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.188250 · Cited by 24
Djajadiningrat‐Laanen, S. C., Galac, S., Boevé, M. H., Boroffka, S. A. E. B., Naan, E. C., IJzer, J., & Kooistra, H. S. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12216 · Cited by 24
Efficacy of adrenal venous sampling is increased by point of care cortisol analysis
Viste, K., Grytaas, M. A., Jørstad, M. D., Jøssang, D. E., Høyden, E. N., Fotland, S. S., Jensen, D., Løvås, K., Thordarson, H. B., Almås, B., et al. (2013) · Endocrine Connections · doi:10.1530/ec-13-0063 · Cited by 24
Primary aldosteronism, diagnosis and treatment in Japan
Takeda, Y., Karashima, S., & Yoneda, T. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9164-6 · Cited by 24
Baguet, J.-P., Steichen, O., Mounier‐Véhier, C., & Gosse, P. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.006 · Cited by 24
Radiologic evaluation of incidentally discovered adrenal masses.
Willatt, J., & Francis, I. R. (2010) · PubMed · Cited by 24
Influence of sampling and storage conditions on plasma renin activity and plasma renin concentration
Lőcsei, Z., Rácz, K., Patócs, A., Kovács, G. L., & Toldy, E. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.013 · Cited by 24
Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism
Honda, K., Sone, M., Tamura, N., Sonoyama, T., Taura, D., Kojima, K., Fukuda, Y., Tanaka, S., Yasuno, S., Fujii, T., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283635789 · Cited by 24
Screening for secondary endocrine hypertension in young patients.
Trifanescu, R. A., Carşote, M., Caragheorgheopol, A., Hortopan, D., Dumitrascu, A. S., Dobrescu, M., & Poiană, C. (2013) · Europe PMC (PubMed Central) · Cited by 24
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives ∗
Maiolino, G., Calò, L. A., & Rossi, G. P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.041 · Cited by 24
Evaluation of patients with adrenal incidentalomas
Kannan, S., Remer, E. M., & Hamrahian, A. H. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328360a43b · Cited by 23
Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults
Nanba, K., Baker, J. E., Blinder, A., Bick, N. R., Liu, C., Lim, J. S., Wachtel, H., Cohen, D. L., Williams, T. A., Reincke, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac408 · Cited by 23
Self-citationMurashima, M., Trerotola, S. O., Fraker, D. L., Han, D., Townsend, R. R., & Cohen, D. L. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00120.x · Cited by 23
Hipertensión por hiperaldosteronismo: más lesión cardiaca, mayor riesgo cardiovascular
Abad-Cardiel, M., Álvarez-Álvarez, B., Luque-Fernandez, L., Fernández, C., Fernández‐Cruz, A., & Claros, N. M. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.07.025 · Cited by 23
Oßwald, A., Fischer, E., Degenhart, C., Quinkler, M. O., Bidlingmaier, M., Pallauf, A., Lang, K., Mussack, T., Hallfeldt, K. K. J., Beuschlein, F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0551 · Cited by 23
O’Shea, P. M., Brady, J. J., Gallagher, N., Dennedy, M. C., & Fitzgibbon, M. C. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215603401 · Cited by 23
Lee, B., Chang, C., Liu, K., Chang, Y., Wu, V., & Huang, K. (2016) · Scientific Reports · doi:10.1038/srep28305 · Cited by 23
Primary aldosteronism in hypertensive patients: clinical implications and target therapy
Papanastasiou, L., Markou, Α., Παππά, Θ., Gouli, A., Tsounas, P., Fountoulakis, S., Kounadi, T., Tsiama, V., Dasou, A., Gryparis, A., et al. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12286 · Cited by 25
L- and T-type calcium channels control aldosterone production from human adrenals
Yang, T., He, M., Zhang, H., Barrett, P. Q., & Hu, C. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0259 · Cited by 23
Discrepant Results of Adrenal Venous Sampling in Seven Patients with Primary Aldosteronism
Zelinka, T., Mašek, M., Vlková, J., Kasalicky, M., Michalský, D., Holaj, R., Petrák, O., Štrauch, B., Rosa, J., Dvořáková, J., et al. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000330720 · Cited by 24
Oki, K., Kopf, P. G., Campbell, W. B., Lam, M. L., Yamazaki, T., Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2012) · Endocrinology · doi:10.1210/en.2012-1557 · Cited by 23
Clinicopathologic Correlates of Primary Aldosteronism
Duan, K., & Mete, Ö. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0156-rs · Cited by 23
Parathyroid Gland Function in Primary Aldosteronism
Bekeran, M., Reincke, M., & Asbach, E. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565224 · Cited by 22
Primary Aldosteronism: Diagnosis and Management
Gyamlani, G. G., Headley, C. M., Naseer, A., Valaulikar, G., & Geraci, S. A. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.06.015 · Cited by 21
Recent advances in the management of secondary hypertension—obstructive sleep apnea
Tokunou, T., & Ando, S. (2020) · Hypertension Research · doi:10.1038/s41440-020-0494-1 · Cited by 23
Endocrine and Hypertensive Disorders of Potassium Regulation: Primary Aldosteronism
Weiner, I. D. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.04.007 · Cited by 21
Jung, J., Barrett, P. Q., Eckert, G. J., Edenberg, H. J., Xuei, X., Tu, W., & Pratt, J. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2196 · Cited by 23
Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism
Matsuda, Y., Kawate, H., Matsuzaki, C., Sakamoto, R., Shibue, K., Ohnaka, K., Anzai, K., Nomura, M., & Takayanagi, R. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0362 · Cited by 22
Imga, N. N., Elalmış, Ö. U., Tuna, M. M., Dogan, B. A., Şahin, D., Berker, D. S., & Güler, S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.37635 · Cited by 22
Chang, C., Lee, B., Liu, K., Chang, Y., Wu, V., & Huang, K. (2016) · Scientific Reports · doi:10.1038/srep37143 · Cited by 22
Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice
Kline, G. A., & Holmes, D. T. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204423 · Cited by 22
Regulation of aldosterone production by ion channels: From basal secretion to primary aldosteronism
Yang, T., He, M., & Hu, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.034 · Cited by 22
Onohara, T., Takagi, T., Yoshida, K., Iizuka, J., Okumi, M., Kondo, T., Ishida, H., & Tanabe, K. (2018) · International Journal of Urology · doi:10.1111/iju.13844 · Cited by 22
Xiao, L., Jiang, Y., Zhang, C., Jiang, L., Zhou, W., Su, T., Ning, G., & Wang, W. (2019) · Clinical Endocrinology · doi:10.1111/cen.13962 · Cited by 22
Outcomes After Surgery for Unilateral Dominant Primary Aldosteronism in Sweden
Sellgren, F., Koman, A., Nordenström, E., Hellman, P., Hennings, J., & Muth, A. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05265-8 · Cited by 22
Tahir, A., McLaughlin, K., & Kline, G. A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0121-y · Cited by 22
the TAIPAI Study Group, Lu, C., Wu, V., Wu, K., Liu, K., Lin, W., Cheng, M., Tzen, K., & Yen, R. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2692-z · Cited by 21
Radiology of the adrenal incidentalomas. Review of the literature
Farrugia, F., Martikos, G., Surgeon, C., Tzanetis, P., Misiakos, E. P., Zavras, N., & Charalampopoulos, A. A. (2017) · Endocrine Regulations · doi:10.1515/enr-2017-0005 · Cited by 21
Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism
Zhang, G., Wang, B., Ouyang, J., Deng, X., Ma, X., Li, H., Wu, Z., Liu, S., Xu, H., & Zhang, X. (2010) · Hypertension Research · doi:10.1038/hr.2010.21 · Cited by 21
Coactivation of SF-1-Mediated Transcription of Steroidogenic Enzymes by Ubc9 and PIAS1
Suda, N., Shibata, H., Kurihara, I., Ikeda, Y., Kobayashi, S., Yokota, K., Murai‐Takeda, A., Nakagawa, K., Oya, M., Murai, M., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1232 · Cited by 21
Luteinizing hormone correlates with adrenal function in postmenopausal women
Saxena, A. R., & Seely, E. W. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31825540c4 · Cited by 21
Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism
Iwakura, Y., Ito, S., Morimoto, R., Kudo, M., Ono, Y., Nezu, M., Takase, K., Seiji, K., Ishidoya, S., Arai, Y., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.05924 · Cited by 21
Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond
Fernandes-Rosa, F. L., Boulkroun, S., Jeunemaı̂tre, X., & Zennaro, M. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565198 · Cited by 21
Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
Kim, J. H., Park, K. S., Hong, A. R., Shin, C. S., Kim, S. Y., & Kim, S. W. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.277 · Cited by 21
Remde, H., Dietz, A., Emeny, R. T., Riester, A., Peters, A., Gala, T. D. L. H., Then, C., Seißler, J., Beuschlein, F., Reincke, M., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001041 · Cited by 23
Miyaji, Y., Kawabata, Y., Joki, H., Seki, S., Mori, K., Kamide, T., Tamase, A., Shima, H., Nomura, M., Kitamura, Y., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0701-5 · Cited by 21
Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity
Hayashi, T., Zhang, Z., Al‐Eyd, G., Sasaki, A., Yasuda, M., Oyama, M., Gómez-Sánchez, C. E., Asakura, H., Seki, T., Mukai, K., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.010 · Cited by 21
The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges
O’Shea, P. M., Griffin, T. P., Denieffe, S., & Fitzgibbon, M. C. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13353 · Cited by 21
Vincent, A. M., Okonkowski, L. K., Brudvig, J. M., Refsal, K. R., Berghoff, N., Olivier, N. B., & Langlois, D. K. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16195 · Cited by 21
Starker, L. F., Kunstman, J. W., & Carling, T. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.008 · Cited by 21
Rege, J., Turcu, A. F., & Rainey, W. E. (2020) · Gland Surgery · doi:10.21037/gs.2019.10.22 · Cited by 22
Oguro, S., Morimoto, R., Seiji, K., Ota, H., Kinoshita, T., Kawabata, M., Ono, Y., Omata, K., Tezuka, Y., Satoh, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18136-5 · Cited by 20
Resistant hypertension: A stepwise approach
Yahr, J., Thomas, G., Calle, J., & Taliercio, J. J. (2023) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.90a.22046 · Cited by 23
What We Know about and What Is New in Primary Aldosteronism
Ekman, N., Grossman, A. B., & Dworakowska, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020900 · Cited by 26
Value of Adrenal Venous Sampling for Lesion Localization in Primary Aldosteronism
Oh, E. M., Lee, K. E., Yoon, K., Kim, S. Y., Kim, H., & Youn, Y. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1695-9 · Cited by 21
Rye, P., Chin, A., Pasieka, J. L., So, B., Harvey, A. M., & Kline, G. A. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12523 · Cited by 20
Rossi, G. P. (2010) · Hypertension Research · doi:10.1038/hr.2010.206 · Cited by 20
Genetic Variations in the KCNJ5 Gene in Primary Aldosteronism Patients from Xinjiang, China
Li, N., Li, H., Zhang, D., Zhang, J., Yao, X., Wang, H., Abulikemu, S., Zhou, K., & Zhang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054051 · Cited by 20
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
